HOME › DRUGS › PALIVIZUMAB
ACTIVE SUBSTANCE / INN

PALIVIZUMAB

Brand name(s): SYNAGIS, Synagis
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
BLA103770
Respiratory Syncytial Virus Infections
ACTIVE SUBSTANCE
Palivizumab
REGULATORS
FDA · EMA
SPONSORS / MAH
SWEDISH ORPHAN, AstraZeneca AB
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SYNAGISBLA103770SWEDISH ORPHANPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
SynagisAstraZeneca ABAuthorised13/08/1999Respiratory Syncytial Virus Infections

FULL INTELLIGENCE ON PALIVIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →